Paxlovid — Not a magic pill, but a very good one
Paxlovid was given an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in December 2021 for the treatment of mild to moderate COVID-19 in certain patients. By the end of February 2023 an estimated 48,000 people with COVID died in the U.S. because they didn’t get Paxlovid. Why didn’t they? Paxlovid is an anti-viral treatment combining two medicines, nirmatrelvir and ritonavir. Taken together, they prevent mild to moderate COVID from progressing to severe disease leading to hospitalization or death. Nirmatrelvir keeps the SARS-CoV-2 virus from spreading ...